Michael D. West, Chief Executive Officer at AgeX Therapeutics, Inc. (AGE), bought 4,000 shares at $3.86 ($15K) on 2018-12-10, disclosed to the SEC on 2018-12-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| BTX | BUY | 2012-05-31 | $41K | — | Filing → |
| BTX | BUY | 2011-06-23 | $44K | — | Filing → |